ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,129.29
1.29%
US Tech 100
17,405.20
1.93%
다우존스 지수
38,709.50
1.27%
Bitcoin
61,834.21
4.59%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Viking Therapeutics Inc (VKTX)

  7. Viking Therapeutics Inc (VKTX) 뉴스

VKTX Viking Therapeutics Inc

77.10
1.34 (1.77%)
최종 업데이트: 02:47:24
15분 지연
기업명 주식 심볼 시장 주식 타입
Viking Therapeutics Inc VKTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
1.34 1.77% 77.10 02:47:24
개장가 저가 고가 종가 전일 종가
74.40 72.88 77.68 75.76
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial..
24/04/202420:31IHMARKETNEWSU.S. Futures Display Mixed Results Amid Earnings, WTI and..
18/04/202405:05PRNUSViking Therapeutics to Report Financial Results for First..
26/03/202420:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
05/03/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202409:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:52EDGAR2Form 8-K - Current report
05/03/202406:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
02/03/202406:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/02/202410:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
28/02/202407:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/02/202406:19PRNUSViking Therapeutics Announces Proposed Public Offering of..
27/02/202421:04EDGAR2Form 8-K - Current report
27/02/202421:03PRNUSViking Therapeutics Announces Positive Top-Line Results from..
10/02/202410:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:01EDGAR2Form 144 - Report of proposed sale of securities
09/02/202409:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202409:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:56EDGAR2Form 144 - Report of proposed sale of securities
09/02/202406:33EDGAR2Form 144 - Report of proposed sale of securities
08/02/202407:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/02/202407:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/02/202406:09EDGAR2Form 8-K - Current report
08/02/202406:05PRNUSViking Therapeutics Reports Fourth Quarter and Year-End 2023..
01/02/202410:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:32EDGAR2Form 144 - Report of proposed sale of securities
01/02/202406:05PRNUSViking Therapeutics to Report Financial Results for Fourth..
31/01/202411:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202406:23EDGAR2Form 144 - Report of proposed sale of securities
20/01/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:36EDGAR2Form 144 - Report of proposed sale of securities
05/01/202411:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202411:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202411:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:02PRNUSViking Therapeutics Presents New Data from Phase 2b VOYAGE..
03/11/202305:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
26/10/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202305:24EDGAR2Form 8-K - Current report
26/10/202305:05PRNUSViking Therapeutics Reports Third Quarter 2023 Financial..
23/10/202320:05PRNUSViking Therapeutics Announces Completion of Enrollment in..
19/10/202305:05PRNUSViking Therapeutics to Report Financial Results for Third..
18/10/202322:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
18/10/202322:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
18/10/202305:05PRNUSViking Therapeutics Presents New Data from Phase 1 Clinical..
11/10/202305:05PRNUSViking Therapeutics to Highlight Data from Phase 1 Clinical..
08/09/202305:05PRNUSViking Therapeutics to Participate at Upcoming Investor..
06/09/202320:03PRNUSViking Therapeutics Announces Initiation of Phase 2 VENTURE..
27/07/202306:26EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/07/202305:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/07/202305:23EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
VKTX
Viking Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유